Oryzon Genomics Cash from Operations (TTM) Trends

Oryzon Genomics SA (ORYZF)

3.31 0.00 (0.00%) USD | OTCM | Sep 24, 16:00

View Cash from Operations (TTM) for ORYZF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Operations (TTM) Chart

Start Trial

View and export this data back to . Start Trial.

Date	Value

Represents the net cash flow from the company's business operations.

View Cash from Operations (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Operations (TTM) Benchmarks

Start Trial

Pharma Mar SA	72.48M
Grifols SA	1.264B
ACADIA Pharmaceuticals, Inc.	160.32M
Alkermes Plc	251.18M
Alnylam Pharmaceuticals, Inc.	885.89M